A clinical-stage biotechnology company focused on developing oral immunotherapies targeting gastrointestinal diseases and immune-related conditions. Its lead programs are derived from bovine colostrum antibodies designed to prevent or treat infectious and inflammatory gut disorders, including travel...
This page tracks all publicly disclosed congressional trades in Imrion Technologies Inc Class A (IMRN), a company in the Healthcare sector. 1 member of Congress has disclosed trades in this stock, including 1 purchase and 0 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-19 | Rohit Khanna | buy | $1K – $15K |